1-3 of 3
Michelle Chen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Pan-Cancer Pharmacogenomic Analysis of Patient-Derived Tumor Cells Using Clinically Relevant Drug Exposures

Stephen H. Chang, Ryan J. Ice, Michelle Chen, Maxim Sidorov, Rinette W.L. Woo, Aida Rodriguez-Brotons, Damon Jian, Han Kyul Kim, Angela Kim, David E. Stone, Ari Nazarian, Alyssia Oh, Gregory J. Tranah, Mehdi Nosrati, David de Semir, Altaf A. Dar, Pierre-Yves Desprez, Mohammed Kashani-Sabet, Liliana Soroceanu, Sean D. McAllister
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2023) 22 (9): 1100–1111.
https://doi.org/10.1158/1535-7163.MCT-22-0486
Published: 05 September 2023
View article titled, Pan-Cancer Pharmacogenomic Analysis of Patient-Derived Tumor Cells Using Clinically Relevant Drug Exposures
Open the PDF for Pan-Cancer Pharmacogenomic Analysis of Patient-Derived Tumor Cells Using Clinically Relevant Drug Exposures in another window
Includes: Supplementary data
Journal Articles

Abstract C089: Adaptive responses of low-grade ovarian cancer cell lines to MEK inhibitor

Kwong-Kwok Wong, Yvonne T Tsang, Michelle Chen, Eucharist H Kun, David M Gershenson
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2019) 18 (12_Supplement): C089.
https://doi.org/10.1158/1535-7163.TARG-19-C089
Published: 01 December 2019
View article titled, Abstract C089: Adaptive responses of low-grade ovarian cancer cell lines to MEK inhibitor
Journal Articles

Abstract A47: DNA-PKcs is amplified in high-grade serous ovarian cancer (HGSC), correlates with poor outcome and drives resistance to platinum therapy via the AKT signaling pathway

Edward Curry, Azadeh Cheraghchi-Bashi-Astaneh, Michelle Chen, Paula Cunnea, De Sousa Camila, Elaina Maginn, Yan Dai, Edison Liu, Harpreet Wasan, Gordon B. Mills, David Bowtell, Hani Gabra, Euan A. Stronach
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2015) 14 (7_Supplement): A47.
https://doi.org/10.1158/1538-8514.PI3K14-A47
Published: 06 July 2015
View article titled, Abstract A47: DNA-PKcs is amplified in high-grade serous ovarian cancer (HGSC), correlates with poor outcome and drives resistance to platinum therapy via the AKT signaling pathway